Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Influenza, Human 4 Vaccine-Preventable Diseases 1 Vaccination Hesitancy 1 Patient Acceptance of Health Care 1 Lymphoma, Non-Hodgkin 1 Leukemia 1 Infections 1 Hematologic Neoplasms 1 Healthy, no Evidence of Disease 1 Health Behavior 1 Colorectal Neoplasms 1 COVID-19 1

Interventions

Cyclophosphamide 21 Cyclosporine 14 fludarabine phosphate 13 Whole-Body Irradiation 13 Peripheral Blood Stem Cell Transplantation 13 Filgrastim 10 Rituximab 9 Mycophenolic Acid 9 Antilymphocyte Serum 9 Radiotherapy 7 Methotrexate 7 Busulfan 7 Melphalan 6 Psychiatric Rehabilitation 5 Etoposide 5 Dexamethasone 5 Cytarabine 5 Aprepitant 5 fludarabine 4 Vincristine 4 Ondansetron 4 Methylprednisolone 4 Granulocyte Colony-Stimulating Factor 4 Doxorubicin 4 Cord Blood Stem Cell Transplantation 4 plerixafor 3 Zidovudine 3 Therapeutics 3 Stem Cell Transplantation 3 Prednisone 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Lymphoma, Non-Hodgkin × Influenza Vaccines × Clear all

NCT01707628 2014-01-31

Rituxivac

St. Antonius Hospital

Phase NA Completed

Influenza, Human, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡